Mesoblast (MESO) Long-Term Investments (2017 - 2025)

Mesoblast (MESO) posted quarterly Long-Term Investments of $1.6 million for Q4 2025, up 28.39% year-on-year from $1.2 million in Q4 2024, and up 11.74% on a QoQ basis from $1.4 million in Q2 2025.

Mesoblast (MESO) Long-Term Investments (2017 - 2025) Analysis & Trends

Mesoblast (MESO) has reported Long-Term Investments for 9 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Long-Term Investments rose 28.39% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 28.39% YoY) and the FY2025 annual result came in at $1.4 million, up 36.88% from the prior year.
  • Long-Term Investments rose to $1.6 million in Q4 2025 per MESO's latest filing, from $1.4 million in the prior quarter.
  • Over the last five years, Long-Term Investments for MESO reached as high as $2.3 million in Q4 2021 and fell as low as $209000.0 in Q2 2021.
  • A 5-year average of $1.6 million and a median of $1.8 million in 2022 frame the typical range for Long-Term Investments.
  • Annual changes were most pronounced in 2022 — Long-Term Investments soared 741.15% — and 2023, when it tumbled 57.62%.
  • Year by year, Long-Term Investments stood at $2.3 million in 2021, then retreated by 16.96% to $1.9 million in 2022, then slumped by 57.62% to $826000.0 in 2023, then soared by 46.25% to $1.2 million in 2024, then increased by 28.39% to $1.6 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $1.6 million, $1.4 million, and $1.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 505,194.89
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mesoblast 2.08 Bn 1.95 Bn - 1.55 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.55 Mn
Jun 30, 2025 1.39 Mn
Dec 31, 2024 1.21 Mn
Jun 30, 2024 1.01 Mn
Dec 31, 2023 826,000.00
Jun 30, 2023 1.76 Mn
Mar 31, 2023 2.03 Mn
Dec 31, 2022 1.95 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 1.76 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.35 Mn
Sep 30, 2021 2.23 Mn
Jun 30, 2021 209,000.00
Mar 31, 2021 1.98 Mn
Dec 31, 2020 1.90 Mn
Sep 30, 2020 1.95 Mn
Jun 30, 2020 -446,000.00
Mar 31, 2020 1.77 Mn
Dec 31, 2019 1.67 Mn